Assessing the Efficacy of Lopinavir/Ritonavir-Based Preferred and Alternative Second-Line Regimens in HIV-Infected Patients: A Meta-Analysis of Key Evidence to Support WHO Recommendations

• Autori principali: Yinqiu Huang (Autore), Xiaojie Huang (Autore), Yadong Luo (Autore), Yihong Zhou (Autore), Xingbao Tao (Autore), Hui Chen (Autore), Aixin Song (Autore), Yaokai Chen (Autore), Hao Wu (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2018-08-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background: Nucleoside reverse transcriptase inhibitors (NRTIs) and non-NRTIs (NNRTIs) with boosted protease inhibitors are included in standardized first-line and second-line regimens. Recent World Health Organization (WHO) guidelines recommend a boosted protease inhibitor (PI) combined with 2 NRTI...